Activation of type IV procollagenases by human tumor-associated trypsin-2
about
Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissueActivation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasionExpression and characterization of trypsinogen produced in the human male genital tractInitiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activationUp-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the ratIdentification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins.Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.Neurogenic components of trypsin- and thrombin-induced inflammation in rat skin, in vivo.Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction.Homocysteine causes cerebrovascular leakage in mice.KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.Human trypsinogen in colorectal cancer.Expression and regulation of MMP-20 in human tongue carcinoma cells.Paneth cell trypsin is the processing enzyme for human defensin-5.Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP.Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.General aspects of anti-angiogenesis and cancer therapy.Pancreatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat.Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation.Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.Proteolytic cleavage and truncation of NDRG1 in human prostate cancer cells, but not normal prostate epithelial cells.Collagen degradation by tumor-associated trypsins.Trypsin-mediated enzymatic degradation of type II collagen in the human vitreous.Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin.Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD.Collagen degradation and MMP9 activation by Enterococcus faecalis contribute to intestinal anastomotic leak.Regulatory mechanism of matrix metalloprotease-2 enzymatic activity by factor Xa and thrombin.Matrix metalloproteinase-9: Many shades of function in cardiovascular disease.Differential gene expression profiling of endometrium during the mid-luteal phase of the estrous cycle between a repeat breeder (RB) and non-RB cows.SAR analysis and bioactive potentials of freshwater and terrestrial cyanobacterial compounds: a review.Keratoconus and crosslinking: pharmacokinetic considerations.Cardiac Physiology of Aging: Extracellular Considerations.Biomarker development, from bench to bedside.The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines.Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis.Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.Matrix metalloproteinase-8/collagenase-2 in childhood otitis media with effusion.Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment.
P2860
Q24337189-12E93A82-A33E-4CEE-A695-3818CB40659BQ28142815-0A50CCBD-85A9-46B8-979F-7209DBD23DF6Q28345000-491D52EA-211D-49A7-ACBE-085341FA077CQ28348328-CF4262D0-37E2-47EE-B256-8B23E825AAADQ28365272-C9499330-4C5B-4170-8DFF-5BF93C5459E5Q28581561-0F411A27-392D-4640-BC6F-8094B8DBEF01Q30951913-944CFCE7-F99B-4A0C-89AD-6652771F413AQ33183384-01BC645E-023C-4E63-B1AA-A8B7726B5C51Q33229884-979C2A5F-BAF1-4A47-AF62-6CD2A317813EQ33611238-F72F4598-D465-443D-BEAD-60BBC70C6928Q33640659-C42BEEE1-B494-491B-9328-65B1F2E47BF7Q33923957-181BE543-01C5-457F-B3E1-79862D40D35CQ33949944-E12113A8-BF3A-4096-8C4F-55CA1E7D4443Q34101591-34A370D0-C4AF-4CA0-A3F0-110CCF5C369FQ34129474-8C4EB214-93DB-45F3-984F-D16CFBC40139Q34295127-E09636B6-4C4B-4B2C-B501-534C7C447F94Q34438694-F7009D67-6ED3-4F65-B95F-9F13E5C610ECQ34452066-2FAB3CA4-B773-45C6-A4F2-07C1A2C1731CQ35098124-AFF8FF1F-25ED-449E-AF06-C3AB3F565940Q36414170-144CFC03-1D47-4BAB-9E3B-D2E35996F015Q36580334-9BBA849C-31F8-4A8A-BC06-EEC241FEAB9CQ36897929-5C89DC12-2C7B-4166-AA1B-BC9BE52FF770Q36921180-53397084-35F2-4B48-892D-34083D8312F9Q36931129-C2193CA6-EFAD-4695-BB77-A2D9DC586C83Q37032800-068DA930-5C63-42C8-AEE0-47FDBCA28F04Q37118844-77BE357F-876D-4400-9C61-2852FAD94934Q37224482-1BD7EF3B-9632-4BED-ADD3-E63EB1412EC8Q37265318-956E1DE0-5C15-4DCB-A840-F0A71073F5FEQ37358104-771611E8-83C4-46E7-A2DD-C91C7B572F6FQ37380847-20AAA998-4F2C-4F18-9500-A5D836780581Q37719802-5360A831-0AB0-47A8-9C03-A69F2D41A505Q38061609-11B1C5FD-A72F-4C9E-9649-F8E2F0246F86Q38133874-CF3CA5B0-4C3A-40E8-8495-9AC3C33101B4Q38542448-5735FA4D-5236-4B50-B90A-0E17605BF93CQ38569348-10903FDE-CF59-4A79-859B-74E272D9C719Q39502453-0CB3B31A-ECAA-4BBD-8E3F-862B5259B2CDQ39630609-02420150-F46A-4C79-8261-3D8E56B5E715Q39796754-7E47E76C-7F55-40A4-999B-ECE4689B24A7Q39820919-749EE61F-9BB2-49B5-90BC-646F65ACB9A5Q39900071-6919578F-1936-475B-B093-FFD0F664CF6B
P2860
Activation of type IV procollagenases by human tumor-associated trypsin-2
description
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1997
@ast
im August 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/08/22)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/08/22)
@nl
наукова стаття, опублікована в серпні 1997
@uk
name
Activation of type IV procollagenases by human tumor-associated trypsin-2
@ast
Activation of type IV procollagenases by human tumor-associated trypsin-2
@en
Activation of type IV procollagenases by human tumor-associated trypsin-2
@nl
type
label
Activation of type IV procollagenases by human tumor-associated trypsin-2
@ast
Activation of type IV procollagenases by human tumor-associated trypsin-2
@en
Activation of type IV procollagenases by human tumor-associated trypsin-2
@nl
prefLabel
Activation of type IV procollagenases by human tumor-associated trypsin-2
@ast
Activation of type IV procollagenases by human tumor-associated trypsin-2
@en
Activation of type IV procollagenases by human tumor-associated trypsin-2
@nl
P2093
P356
P1476
Activation of type IV procollagenases by human tumor-associated trypsin-2
@en
P2093
A. Tuuttila
E. Koivunen
H. Tschesche
J. Leinonen
J. Tyynelä
O. Teronen
P. Heikkilä
P304
21067–21074
P356
10.1074/JBC.272.34.21067
P407
P577
1997-08-22T00:00:00Z